Abstract
Anal HPV infection is particularly prevalent among men who have sex with men (MSM). The purpose of this study was to understand the status and influencing factors of HPV infection in MSM in Urumqi, Xinjiang, in order to provide suggestions for policy formulation. A prospective cohort study was conducted among HIV-negative MSM in Urumqi Xinjiang between April 2016 and June 2023. 824 MSM were recruited. Data were collected anal swab results from self-administered questionnaires and laboratory tests. A Cox regression model was employed to analyze factors associated with HPV infection. The prevalence rates of high-risk HPV and low-risk HPV were 37.99% and 25.97%. Receptive anal intercourse is a well-established risk factor for both incident and persistent HPV infections among MSM. For new high-risk HPV infections, the adjusted hazard ratio is 1.55 (95% CI: 1.28—1.89), and for persistent high-risk HPV infections, the aHR is 1.95 (95% CI: 1.48—2.57). Similarly, for low-risk HPV, receptive anal intercourse increases the risk of incidence (aHR = 1.34, 95% CI: 1.07–1.67) and persistent infection (aHR = 1.64, 95% CI: 1.18—2.29). Seeking sexual partners in bathhouses raised the risk of low-risk HPV infections (aHR = 1.36, 95% CI: 1.05—1.76). Young MSM may face a higher risk of HPV infection. Implementing targeted HPV vaccination catch-up programs for the MSM population in Urumqi could offer significant societal benefits.




Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Smith JS, Gilbert PA, Melendy A, et al. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health. 2011;48(6):540–52.
Dunne EF, Nielson CM, Stone KM, et al. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006;194(8):1044–57.
Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012;13(5):487–500.
Méndez-Martínez R, Rivera-Martínez NE, Crabtree-Ramírez B, et al. Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men. BMC Infect Dis. 2014;14(1):671.
de Sanjosé S, Brotons M, Pavón MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2–13.
Berry JM, Jay N, Cranston RD, et al. Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer. 2014;134(5):1147–55.
Tian T, Mijiti P, Bingxue H, et al. Prevalence and risk factors of anal human papillomavirus infection among HIV-negative men who have sex with men in Urumqi city of Xinjiang Uyghur Autonomous Region, China. PLoS ONE. 2017;12(11):e0187928.
Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health. 2010;46(4 Suppl):S20-26.
de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70.
Safaeian F, Ghaemimood S, El-Khatib Z, et al. Burden of cervical cancer in the eastern mediterranean region during the years 2000 and 2017: retrospective data analysis of the global burden of disease study. JMIR Public Health Surveill. 2021;7(5):e22160.
Lin C, Franceschi S, Clifford GM. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(2):198–206.
Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal hpv infection and anal intraepithelial neoplasia. N Engl J Med. 2011;365(17):1576–85.
Stanley MA, Winder DM, Sterling JC, et al. HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues. BMC Cancer. 2012;12:398.
Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401–11.
Meites E, Wilkin TJ, Markowitz LE. Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States. Hum Vaccin Immunother. 2022;18(1):2016007.
Harper DM, DeMars LR. HPV vaccines—a review of the first decade. Gynecol Oncol. 2017;146(1):196–204.
Liu L, Zhang G, Zhang Z, et al. Reinfection of nine-valent human papillomavirus vaccine types among hiv-negative men who have sex with men: a prospective cohort study. Front Public Health. 2022;10: 896479.
Donà MG, Giuliani M, Rollo F, et al. Incidence and clearance of anal high-risk human papillomavirus infection and their risk factors in men who have sex with men living with HIV. Sci Rep. 2022;12(1):184.
Nyitray AG, Fujimoto K, Zhao J, et al. Prevalence of and risk factors for anal human papillomavirus infection in a sample of young, predominantly black men who have sex with men, Houston. Texas J Infect Dis. 2018;217(5):777–84.
Patel P, Bush T, Conley L, et al. Prevalence, incidence, and clearance of human papillomavirus types covered by current vaccines in men with human immunodeficiency virus in the SUN study. J Infect Dis. 2020;222(2):234–42.
Zou H, Tabrizi SN, Grulich AE, et al. Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study. Lancet Infect Dis. 2015;15(1):65–73.
Marra E, Lin C, Clifford GM. Type-specific anal human papillomavirus prevalence among men, according to sexual preference and HIV status: a systematic literature review and meta-analysis. J Infect Dis. 2019;219(4):590.
Galea JT, León SR, Peinado J, et al. HPV knowledge, burden and genital wart location among heterosexually identified versus homosexually identified men who have sex with men in Lima, Peru: cross-sectional results from a cohort study. BMJ Open. 2017;7(10):e017338.
Giuliano AR, Palefsky JM, Goldstone SE, et al. High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men. J Infect Dis. 2024;229(3):707–18.
Nowak RG, Gravitt PE, He X, et al. Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men in Nigeria. Sex Transm Dis. 2016;43(4):243–8.
Lee A, Gaither TW, Langston ME, et al. Lubrication practices and receptive anal sex: implications for STI transmission and prevention. Sexual Medicine. 2021;9(3):100341.
Zhang J, Shen WW, Gao MY, et al. Correlation between HIV infection, club drug use and anal canal human papillomavirus infection in men who have sex with men in Taizhou. Zhonghua liu xing bing xue za zhi Zhonghua liuxingbingxue zazhi. 2022;43(3):380–6.
Maxwell S, Shahmanesh M, Gafos M. Chemsex behaviours among men who have sex with men: a systematic review of the literature. Int J Drug Policy. 2019;63:74–89.
Wang L, Santella AJ, Wei X, et al. Prevalence and protective factors of HIV and syphilis infection among men who have sex with men in Northwest China. J Med Virol. 2020;92(8):1141–7.
Chen X, Li X, Zheng J, et al. Club drugs and HIV/STD infection: an exploratory analysis among men who have sex with men in Changsha, China. PLoS ONE. 2015;10(5): e0126320.
Knight DA, Jarrett D. Preventive health care for men who have sex with men. Am Fam Physician. 2015;91(12):844–51.
Grov C. HIV risk and substance use in men who have sex with men surveyed in bathhouses, bars/clubs, and on craigslist.org: venue of recruitment matters. AIDS and Behavior. 2012;16(4):807–17.
Qi J, Zhang D, Fu X, et al. High risks of HIV transmission for men who have sex with men — a comparison of risk factors of HIV infection among MSM associated with recruitment channels in 15 cities of China. PLoS ONE. 2015;10(4): e0121267.
Zheng L. The dyadic effects of top/bottom sexual self-labels and partner sexual role requirements on facial masculinity preferences among gay and bisexual men in China. J Sex Res. 2021;58(1):122–8.
Pollock KG, Wallace LA, Wrigglesworth S, et al. HPV vaccine uptake in men who have sex with men in Scotland. Vaccine. 2019;37(37):5513–4.
Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017*. Annals of Internal Medicine. 2017; 166(3): 209–219
Goldstone SE, Giuliano AR, Palefsky JM, et al. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2022;22(3):413–25.
Naidu J, Polonijo AN. Barriers and facilitators to HPV and meningococcal vaccination among men who have sex with men: a qualitative study. BMC public health. 2023;23(1):933. https://doi.org/10.1186/s12889-023-15847-w.
Soe NN, Ong JJ, Ma X, et al. Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness. Hum Vaccin Immunother. 2018;14(12):3010–8.
Chan PS, Fang Y, Chidgey A, et al. Would Chinese men who have sex with men take up human papillomavirus (HPV) screening as an alternative prevention strategy to HPV vaccination? Front Med (Lausanne). 2022;9:904873.
Chen Q, Zhou T, Zhong X. Factors related to HPV vaccination intention among MSM in China: a Bayesian network model. Int J Environ Res Public Health. 2022;19(23):15532. https://doi.org/10.3390/ijerph192315532.
Tian T, Wang D, Papamichael C, et al. HPV vaccination acceptability among men who have sex with men in Urumqi. China Hum Vaccin Immunother. 2019;15(4):1005–12.
Funding
This study was funded by the Open Project of Key Laboratory of AIDS Prevention and Control Research in Xinjiang (XJYS1706-2021011), Science and Technology Innovation Team (Tianshan Innovation Team) Project of Xinjiang Uighur Autonomous Region (2022TSYCTD0013), The Scientific Research Innovation Team Project for Xinjiang Medical University (Grant no. XYD2024C04), The 14-th Five-Year Plan Distinctive Program of Public Health and Preventive Medicine in Higher Education, Key Laboratory of Environmental Exposome, Xinjiang Medical University.
Author information
Authors and Affiliations
Contributions
Guozhen Zhang: Conceptualization, Writing—Review & Editing; Heng Yang: Formal analysis, Writing—Original Draft, Visualization; Juyuan Bian: Formal analysis, Software, Validation; Shulipan Asilibieke: Project Administration, Data Curation; Tian Tian: Project Administration, Data Curation; Henry S Lynn: Writing—Review & Editing; Jianghong Dai: Project Administration, Writing—Review & Editing.
Corresponding author
Ethics declarations
Competing Interests
There are no conflicts of interest for any of the study authors.
Ethical Approval
All participants provided written informed consent. The First Affiliated Hospital of Xinjiang Medical University's Ethics Committee reviewed and approved the study (Batch Number: 20160512–11).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, G., Yang, H., Bian, J. et al. Infection and Persistent Infection of Human Papillomavirus Among HIV-Negative Men Who Have Sex with Men in Xinjiang, China: A Prospective Cohort Study. AIDS Behav 29, 834–847 (2025). https://doi.org/10.1007/s10461-024-04569-8
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1007/s10461-024-04569-8


